Effect of Dupilumab on patient-reported breathing and rescue medication use

J. Corren (Los Angeles, United States of America), M. Castro (Kansas City, United States of America), J. Maspero (Buenos Aires, Argentina), W. Busse (Madison, United States of America), A. Valero Santiago (Barcelona, Spain), P. Kuna (Lodz, Poland), N. Daizadeh (Cambridge, United States of America), N. Pandit-Abid (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), A. Khan (Chilly-Mazarin, France), S. Kamat (Tarrytown, United States of America)

Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Session: Management of allergy, asthma and COPD
Session type: E-poster session
Number: 233
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Corren (Los Angeles, United States of America), M. Castro (Kansas City, United States of America), J. Maspero (Buenos Aires, Argentina), W. Busse (Madison, United States of America), A. Valero Santiago (Barcelona, Spain), P. Kuna (Lodz, Poland), N. Daizadeh (Cambridge, United States of America), N. Pandit-Abid (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), A. Khan (Chilly-Mazarin, France), S. Kamat (Tarrytown, United States of America). Effect of Dupilumab on patient-reported breathing and rescue medication use. 233

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of short term supervised breathing exercises added to regular medications over nocturnal symptoms, requirement of rescue medication and spirometric variables in asthma patients
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012


Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013

Impact of morning symptoms experienced by COPD patients on exacerbation risk, rescue inhaler usage and normal daily activities
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012


Impact of lifestyle modification as part of a sleep service on CPAP requirement
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018


Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Year: 2020




Effectiveness of prolonged cholinolytic in complex basic therapy on the tolerability of physical load in severe bronchial asthma patients
Source: Annual Congress 2008 - Markers and triggers of asthma
Year: 2008

Impact of add-on medications on patient‘s satisfaction in patients with asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 273s
Year: 2005

Effect of CPAP adherence on depression in OSA patient
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020


The effect of frequent use of hypnotics on HRQOL in patients receiving LTOT and/or long-term NIV
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015


Does chronic opioid use impact OSA diagnosis and response to treatment with CPAP?
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020


Physician‘s perception of pediatric asthma control is influenced by the use of medication
Source: Eur Respir J 2003; 22: Suppl. 45, 365s
Year: 2003

Once-daily QVA149 improves dyspnoea, lung function and reduces rescue medication use in symptomatic patients with COPD using LAMA as prior medication: The BLAZE study
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014


Reproducibility of an asthma symptoms and rescue medication diary: Paper and AM3Ô modes
Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Year: 2011

Impact of bronchodilator therapy on diaphragmatic function in sleep in COPD
Source: Virtual Congress 2020 – Exploring respiratory function
Year: 2020




Use of asthma rescue medication in response to nonsymptom triggers
Source: Eur Respir J 2001; 18: Suppl. 33, 48s
Year: 2001

Daily pattern of ß2-agonists: understanding real-life use of rescue medication
Source: International Congress 2017 – Asthma management
Year: 2017

Effect of dupilumab on improving physical activity in patients with severe asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Increased respiratory symptoms in COPD patients on withdrawal of therapy: evidence of long-term efficacy gains with formoterol turbuhaler
Source: Eur Respir J 2002; 20: Suppl. 38, 243s
Year: 2002

Influence of personal characteristics of patients with bronchial asthma on their medication adherence
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018